These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6570081

  • 1. C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections.
    Teisner B, Elling P, Svehag SE, Poulsen L, Lamm LU, Sjöholm A.
    Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):341-9. PubMed ID: 6570081
    [Abstract] [Full Text] [Related]

  • 2. Factor I deficiency and C3 nephritic factor: immunochemical findings and association with Neisseria meningitidis infection in two patients.
    Teisner B, Brandslund I, Folkersen J, Rasmussen JM, Poulsen LO, Svehag SE.
    Scand J Immunol; 1984 Oct; 20(4):291-7. PubMed ID: 6239368
    [Abstract] [Full Text] [Related]

  • 3. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
    Wahn V, Müller W, Rieger C, Rother U.
    Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Role of the C3 nephritic factor in the pathogenesis of glomerulonephritis].
    Belovezhov N, Neshev Kh.
    Vutr Boles; 1978 Aug; 17(1):9-12. PubMed ID: 349880
    [No Abstract] [Full Text] [Related]

  • 6. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT, Imherr SM, Strauss S, Gewurz H, Mold C.
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia.
    Edwards KM, Alford R, Gewurz H, Mold C.
    N Engl J Med; 1983 May 12; 308(19):1138-41. PubMed ID: 6835339
    [No Abstract] [Full Text] [Related]

  • 11. C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytes.
    Mold C, Medof ME.
    Mol Immunol; 1985 May 12; 22(5):507-12. PubMed ID: 3848661
    [Abstract] [Full Text] [Related]

  • 12. [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].
    Nakanishi I.
    Nihon Jinzo Gakkai Shi; 1981 Jun 12; 23(6):719-32. PubMed ID: 6914399
    [No Abstract] [Full Text] [Related]

  • 13. Bactericidal capacity against Neisseria meningitidis of normal human serum and sera with functional deficiencies of the third and eight complement factor.
    Strate M, Olsen H, Teisner B.
    Eur J Clin Invest; 1987 Jun 12; 17(3):226-30. PubMed ID: 3113967
    [Abstract] [Full Text] [Related]

  • 14. [Barraquer and Simons lipodystrophy. Complement anomalies and cutaneous leukocytoclasic vasculitis].
    Perrot H, Delaup JP, Chouvet B.
    Ann Dermatol Venereol; 1987 Jun 12; 114(9):1083-91. PubMed ID: 3434945
    [Abstract] [Full Text] [Related]

  • 15. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
    Clardy CW, Forristal J, Strife CF, West CD.
    Clin Immunol Immunopathol; 1989 Mar 12; 50(3):333-47. PubMed ID: 2917424
    [Abstract] [Full Text] [Related]

  • 16. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
    Myers B, Chambers R, Anderson A, Barry R, Wallington T, Whicher J.
    J Clin Lab Immunol; 1986 Apr 12; 19(4):201-4. PubMed ID: 3723590
    [Abstract] [Full Text] [Related]

  • 17. C3 nephritic factor determination. A comparison between two methods.
    López-Trascasa M, Marín MA, Fontán G.
    J Immunol Methods; 1987 Apr 02; 98(1):77-82. PubMed ID: 3559214
    [Abstract] [Full Text] [Related]

  • 18. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J, Lesavre P.
    Nouv Presse Med; 1979 Jul 07; 8(30):2447-8. PubMed ID: 493036
    [No Abstract] [Full Text] [Related]

  • 19. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 20. Hypocomplementemic proliferative glomerulonephritis with C3 nephritic-factor-like activity in multiple myeloma.
    Bourke E, Campbell WG, Piper M, Check IJ.
    Nephron; 1989 Jun 15; 52(3):231-7. PubMed ID: 2662048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.